TSX:XNDUSoftware
Does Quantum‑Enabled Cancer Drug Discovery Shift the Bull Case For Xanadu Quantum Technologies (TSX:XNDU)?
Xanadu Quantum Technologies and the University of Alberta recently announced a research partnership to develop quantum algorithms that can accelerate the design of next‑generation photosensitizers for photodynamic cancer therapy, aiming to overcome classical computational limits in drug discovery.
This move positions Xanadu at the intersection of quantum computing and oncology-focused pharmaceutical research, potentially broadening the real‑world applications of its quantum drug design...